Podcasts about therapeutic goods administration tga

Proactive's Tylah Tully breaks down ‘Just the Facts' of the latest news from Recce Pharmaceuticals Ltd (ASX:RCEOTC:RECEF). Recce has completed dosing for all 30 participants in its Phase II clinical trial of RECCE® 327 Topical Gel (R327G). This trial focused on treating Acute Bacterial Skin and Skin Structure Infections (ABSSSI). Conducted as an open-label study, it evaluated the safety, tolerability, pharmacokinetics and efficacy of R327G, applied daily over either seven or 14 days. Preliminary results indicated complete cures or significant symptom improvement in participants, with no serious adverse events reported. The full trial results are expected in the first quarter of this year. R327G is a synthetic anti-infective designed to address antibiotic-resistant infections. The company highlighted its strong safety profile and efficacy, particularly in patients with highly resistant bacterial infections. Recce plans to utilise the data to support regulatory submissions to the US Food and Drug Administration (FDA) and the Therapeutic Goods Administration (TGA). A Phase III trial is scheduled to begin in Australia during the first half of this year. #ProactiveInvestors #ReccePharmaceuticals, #ASX #ClinicalTrials, #Phase2Trial, #RECCE327, #TopicalGel, #ABSSSI, #AntibioticResistance, #SyntheticAntiInfective, #PharmaceuticalInnovation, #PatientSafety, #Efficacy, #FDAApproval, #TGAApproval, #DrugDevelopment, #HealthcareAdvances, #InfectiousDisease, #Australia, #Phase3Trial, #Biotechnology, #MedicalResearch

In this must-listen episode, I sit down with Professor Tony Lawler, Deputy Secretary of the Australian Federal Government's Health Products Regulation Group—home to the Therapeutic Goods Administration (TGA). We dive into the essential obligations that every Australian health professional needs to know when it comes to discussing, representing, and advertising therapeutic goods—whether in their practice, marketing, or online presence. In today's digital world, where our footprints are permanent, it's crucial to stay compliant with TGA regulations. Tony sheds light on the legislation and regulations that affect us all, and what I learned was nothing short of eye-opening. This is easily one of my top episodes to date. If you're an Aussie health professional, this episode is non-negotiable. Listen twice. Share it with your colleagues. We're all accountable to these rules, and as Tony made clear, ignorance is no excuse for non-compliance. Grab a cuppa (or something stronger) and settle in for 45 minutes of essential, eye-opening content. For more information on the TGA advertising guidelines, visit the ⁠TGA Advertising Hub⁠. **All opinions in this podcast are those of the host and guest, and do not reflect the views of any affiliated organizations.

Rogue chemists are reportedly selling unapproved replicas of popular weight loss drug, Ozempic to vulnerable Aussies. The practice is in response to soaring demand for the drug, with thousands of patients desperate to get their hands on it. Luke Grant chats with Chief Medical Advisor of the Therapeutic Goods Administration (TGA), Professor Robyn Langham, about the potential dangers of the unregulated drugs and why you shouldn't be taking TGA approved Ozempic without a valid medical reason.See omnystudio.com/listener for privacy information.

Heyday Medical is a GP clinic with a difference. Its six doctors and nursing team focus on providing holistic care and consults for natural therapies to over 4,500 patients and counting. Heyday Medical also has a range of sustainably grown, Australian cannabis medicines (Including flower, oils, gummies and more). It began as a start-up between two siblings. Dr. Jim Connell, a practicing GP and his sister Phoebe Macleod an Intellectual Property Lawyer, who was 3 months into her maternity leave with her new baby, when their mum was diagnosed with late-stage pancreatic cancer, and their world was turned upside down. Watching the devastating pain their mother was enduring from cancer, Phoebe and Jim came together to combine their career knowledge to create and provide comfort for their mother's symptoms and pain management before her passing. Together they committed to developing unique and medically focused cannabis medicines and in-turn creating their start up - ‘Heyday', a namesake of the Art Gallery their mum, Helen, owned in her 20's in Prahran, Melbourne.Prescription medicinal marijuana has been approved and legally accessible In Australia since 2017, but still hasn't become a part of the standard medical ‘go-to' tool kit for regular GP's and specialists, although showing astounding results in chronic pain, anxiety, insomnia and so much more. So we speak with Phoebe to understand what it's been like to create a family business from collective pain and turn their trauma into treatment for others.   Rebecca Bull – Creator / Executive Producer / Co-Host Zoe Weir – Co-Creator / Co – Host Sophie Jackson – Producer  Social Media – Naughty Nancy Social Media Agency Website / Brand Design – Foster Creative Video Editor – Luke Morgan DISCLAIMER: The information on this podcast is provided for educational and informational purposes only and is not medical advice. Heyday Medical is not promoting the use of medicinal cannabis. Medicinal cannabis in Australia is scheduled medication and regulated by the Therapeutic Goods Administration (TGA). Details about medicinal cannabis as a scheduled drug can be found on the TGA website. If you think medicinal cannabis may be right for you, please consult with a doctor.See omnystudio.com/listener for privacy information.

A vaccine has been approved for the first time in Australia to combat highly infectious Respiratory Syncytial Virus (RSV). The Therapeutic Goods Administration (TGA) has approved AREXVY to be used as a RSV vaccine for Australians aged 60 and over. - අධික ලෙස බෝවන Respiratory Syncytial Virus හෙවත් RSV වලට එරෙහිව සටන් කිරීමට හැකි එන්නතක් ඕස්ට්‍රේලියාවේ ප්‍රථම වරට භාවිතය සඳහා අනුමත කර තිබේ. ඕස්ට්‍රේලියාවේ ඖෂධ නියාමන අධිකාරිය විසින් AREXVY එන්නත සඳහා මෙලෙස අනුමැතිය ලබා දී ඇත. මෙය අනුමත කර තිබෙන්නේ වයස අවුරුදු 60 ඉක්මවූ පුද්ගලයින් සඳහායි.

On today's show, Luke Andreski will discuss "101 Days of Gaza Bombardment." GUEST 1 OVERVIEW: Luke Andreski is an Author and Campaigner. GUEST 2 OVERVIEW: Dr. Altman is a well-known Australian authority on clinical trials and regulatory affairs with more than 40 years of experience working with the Therapeutic Goods Administration (TGA). Dr. Altman has also presented to the Cross Party COVID Inquiry held in Brisbane and New Zealand on the topic of COVID vaccines, highlighting their classification as 'countermeasures' developed by the US Department of Defense.

Managing Director of Emyria Ltd (ASX:EMD) Dr. Michael Winslo speaks to Thomas Warner from Proactive after the clinical-stage biotech company announced it has been granted Authorised Prescriber approval from the Therapeutic Goods Administration (TGA) for MDMA-assisted therapy in post-traumatic stress disorder (PTSD) care. Winslo explains that Authorized Prescriber Status allows Emyria to prescribe MDMA for post-traumatic stress disorder (PTSD) and psilocybin for treatment-resistant depression, following the TGA's groundbreaking decision to reschedule these substances. Achieving this status demonstrates Emyria's compliance with TGA's stringent requirements, including specialist qualifications, appropriate training, and clinical governance. Currently, Emyria is conducting clinical trials using MDMA-assisted therapy, laying the groundwork for broader treatment options. With a significant number of Australians suffering from PTSD, many of whom are treatment-resistant, Winslow believes there is a pressing need for more effective treatments. Emyria aims to replicate the promising results of international clinical trials, offering new treatment options under strict TGA guidelines. He makes it clear that Emyria's current priority is delivering these advanced treatments effectively and sensibly, using the generated revenue and data to support further drug development and innovation. #EmyriaLimited #MichaelWinslow #MentalHealth #PTSDTreatment #MDMATherapy #Psilocybin #InnovativeTreatments #HealthcareInnovation #ClinicalTrials #AuthorizedPrescriber #TGA #AustralianHealth #TherapeuticGoodsAdministration #Biotech #DrugDevelopment #ProactiveInterview #HealthcareNews #MentalHealthAwareness #PsychedelicMedicine #TreatmentResistantDepression #ProactiveInvestors #biotech #health #mdma #psylocibin #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

GUEST OVERVIEW: Dr Altman is a well-known Australian authority on clinical trials and regulatory affairs with more than 40 years of experience working with the Therapeutic Goods Administration (TGA). More recently Dr. Altman has presented to the Cross Party COVID Inquiry held in Brisbane and NZ in relation to the COVID vaccines.

GUEST OVERVIEW: Dr Altman is a well-known Australian authority on clinical trials and regulatory affairs with more than 40 years of experience working with the Therapeutic Goods Administration (TGA). More recently Dr. Altman has presented to the Cross Party COVID Inquiry held in Brisbane and NZ in relation to the COVID vaccines.

On today's show, Dr. Philip Altman discusses different covid vaccine batches.  GUEST 1 OVERVIEW: Dr Altman is a well-known Australian authority on clinical trials and regulatory affairs with more than 40 years of experience working with the Therapeutic Goods Administration (TGA). More recently Dr. Altman has presented to the Cross Party COVID Inquiry held in Brisbane and NZ in relation to the COVID vaccines. Topic ... COVID vaccines are really not 'pharmaceuticals' but classified as 'countermeasures' developed by the US Department of Defense'. GUEST 2 OVERVIEW: Anna McGovern is a ​British ​TV Commentator ​at ​TalkTV and GBNews​ ​and also is a writer​ and a recipient of a @DianaAwardLegacy.  

It's better late than never, and in episode 1.08 of Crossover Connections with Jack Wang, we discuss the new ban on vaping imposed by the Therapeutic Goods Administration (TGA) in Australia, and dive into the impact of e-cigarettes on our long-term health.The Connect:* Gen Z is the most difficult generation in the workplace according to a poll of >1300 US managers (2:40)Whose job is it anyway?* You should never ask this question at any job interviews (9:11)The Circuit:* Paracetamol Pack Sales cut back amid fears of overdose (16:31)* What does vaping do to your body? (20:10)* 3 key vaping Facts (25:31)* How nicotine changes brain chemistry in mice over generations (29:03)* How e-cigarette and tobacco industries targeted young people (31:25)Crossover of the Week:* What policies can actually stop vaping in schools? (35:06)Show Notes:Gen Z most difficult to work with: https://nypost.com/2023/04/21/gen-z-is-the-most-difficult-generation-in-the-workplace-poll/Gen Z already burnt out: https://nypost.com/2023/02/17/new-gen-z-workers-already-burnt-out-and-disconnected/Never ask this question as a candidate at a job interview: https://www.cnbc.com/2023/04/13/never-ask-this-question-at-a-job-interview-says-ceo-why-its-an-immediate-red-flag.html?utm_content=Main&utm_medium=Social&utm_source=Facebook&fbclid=IwAR0a6wFU3q16zA-yLxSOG8PkL5uaemQrMb3zrwXaRRedlExiBiCjhlYboL0#Echobox=1682008238TGA bans large packs of Panadol over OD concerns: https://www.abc.net.au/news/2023-05-03/paracetamol-maximum-packet-size-tga/102300266Australia bans recreational vapes: https://www.abc.net.au/news/2023-05-02/federal-government-bans-import-recreational-vapes/102292306Is vaping worse than smoking?https://www.hopkinsmedicine.org/health/wellness-and-prevention/5-truths-you-need-to-know-about-vapingNIcotine in mice impairs behaviour across multiple generations: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6191076/The vaping industry's secret plan: https://www.abc.net.au/news/health/2022-12-22/vaping-e-cigarette-tricks-loopholes-industry-target-young-people/101793648Vaping is not doing what it claims to do:https://theconversation.com/a-damning-review-of-e-cigarettes-shows-vaping-leads-to-smoking-the-opposite-of-what-supporters-claim-180675#:~:text=People%20who%20have%20never%20smoked,have%20never%20used%20e%2Dcigarettes.How do we regulate vaping?https://www.abc.net.au/news/2023-02-24/australia-vaping-problem-health-policy-solution/102012768Last week's video: https://youtu.be/x__Tgd3unJc Get full access to BioLab Collective with Jack Wang at biolabcollective.substack.com/subscribe

There are new restrictions on the amount of painkillers people in Australia can purchase. The Therapeutic Goods Administration has announced paracetamol packs will be reduced from 20 to 16 tablets, while pharmacy packs of the analgesic will be cut from 100 to 50. - வலி நிவாரணிகள் எவ்வளவு வாங்கலாம் என்பதற்குப் புதிய அளவுக் கட்டுப்பாடுகள் நாட்டில் அறிமுகமாகவுள்ளன. பரவலாகப் பயன்படுத்தப்படும் Paracetamol இனிமேல் 20 கொண்ட பொதிகளில் கிடைக்காது. அதிக பட்சம் அதில் 16 மட்டுமே இருக்கும். மருந்தகங்கள் விற்கும் பொதிகளில் 100 மாத்திரைகளுக்குப் பதிலாக 50 மட்டுமே விற்கப்படலாம் என்று மருந்துகளைக் கட்டுப்படுத்தும் The Therapeutic Goods Administration – அல்லது TGA அறிவித்துள்ளது.

On today's show we discuss COVID vaccines are really not 'pharmaceuticals' but classified as 'countermeasures' developed by the US Department of Defense. GUEST OVERVIEW: Dr Altman is a well-known Australian authority on clinical trials and regulatory affairs with more than 40 years of experience working with the Therapeutic Goods Administration (TGA). More recently Dr. Altman has presented to the Cross Party COVID Inquiry held in Brisbane and NZ in relation to the COVID vaccines.

In Radiotherapy's first show back for 2023, Dr Sharma explores the decision by the Therapeutic Goods Administration (TGA) to permit psychiatrists in Australia to prescribe psilocybin for treatment resistant depression, and MDMA for post traumatic stress disorder (PTSD); Dr Dilemma explores the upcoming trial which will allow some pharmacists to prescribe basic medicines; Dr Neo unpacks the recent popularity of Semaglutide as a weight loss drug; and the team canvass the new Strengthening Medicare report. With presenters Panel Beater, Dr Dilemma, Dr Sharma, and Dr Neo.Website: https://www.rrr.org.au/explore/programs/radiotherapyFacebook: https://www.facebook.com/RadiotherapyOnTripleR/Twitter: https://twitter.com/_radiotherapy_Instagram: https://instagram.com/radiotherapy_tripler

Peter Hunt AM has been a leading advocate for change to the legal classification of psychedelic medicines in Australia, with the hope that it will revolutionise mental healthcare and outcomes for those across Australia. On this episode of The Lawyers Weekly Show, host Jess Feyder speaks with Mr Hunt, co-founder of the organisation Mind Medicine Australia, about psychedelic medicines and the changing legalities in Australia. Mr Hunt discusses the mental health epidemic plaguing Australia and how psychedelic medicines such as psilocybin and MDMA can address the mental suffering of people with treatment-resistant depression, severe post-traumatic stress disorder, and other mental health issues. Mr Hunt discusses the legal barriers and complications surrounding access for patients and speaks about the essential role lawyers can play over the coming years. Editor's note: After the episode was recorded, the Therapeutic Goods Administration (TGA) announced that certain psychedelic medicines would be rescheduled (Friday, 3 February) so that they could be used under psychiatric guidance. If you like this episode, show your support by rating us or leaving a review on Apple Podcasts (The Lawyers Weekly Show) and by following Lawyers Weekly on social media: Facebook, Twitter and LinkedIn. If you have any questions about what you heard today, any topics of interest you have in mind, or if you'd like to lend your voice to the show, email editor@lawyersweekly.com.au for more insights!

Kate Everitt and Julie Moulder co-founders of The Fix Company join us in this Mindfulbiz Podcast episode. The Fix is Australia's first period supplement range. Both women were driven by a passion and purpose to revolutionise how we approach menstruation by providing active period relief. Harnessing their combined expertise and fierce passion, they are on a mission to reshape female wellbeing. They've worked side-by-side with their contract manufacturer who had an extensive R&D team, scientists and chemists. Once formulated, the products were tested and approved by the Therapeutic Goods Administration (TGA). In this episode we talk about their business journey. Whilst they are still in start-up mode, they've certainly made an impact! www.relauncher.com.au www.instagram.com/relauncher_alison

On 1 Feb the Therapeutic Goods Administration (TGA) announced that - from the 1st July 2023 - the medical use of MDMA and Psilocybin will be rescheduled from Schedule 9 (prohibited substances) to Schedule 8 (controlled medicines) of the Poisons Standard. This will enable authorised psychiatrists to prescribe these substances for treatment-resistant depression and treatment resistant post-traumatic stress disorder. Today we speak with Peter Hunt who is not your conventional mental health practitioner. Peter is in fact a career investment banker with 35 years of experience as a banker. He has advised local and multi-national companies and governments in Australia.  The reason why we're speaking with Peter is also an active philanthropist involved in funding, developing and scaling social sector organisations with the goal to create a better and fairer world.  Specifically, Peter is the Chairman of Mind Medicine Australia which he established with his wife, Tania de Jong, in 2018. Mind Medicine Australia supports clinical research and works towards regulatory-approved and evidence-based psychedelic-assisted therapies.   In our conversation today we explore a course that Mind Medicine Australia has developed to help train the next generation of clinicians. Peter shares his views on the applications of MDMA and psychedelic assisted therapy as well as some of his own personal journey.   You can connect with Mind Medicine Australia via their website mindmedicineaustralia.org.au

GUEST HOST: Jeremy Beck On today's show we discuss COVID vaccines are really not 'pharmaceuticals' but classified as 'countermeasures' developed by the US Department of Defense. GUEST OVERVIEW: Dr Phillip Altman is a well-known Australian authority on clinical trials and regulatory affairs with more than 40 years' experience working with the Therapeutic Goods Administration (TGA). More recently Dr Altman has presented to the Cross Party COVID Inquiry held in Brisbane and NZ in relation to the COVID vaccines.

On today's show Dr Phillip Altman discusses the latest COVID medical reality now that the former Australian Medical Association president has gone public with her and her partner's adverse reactions to the Pfizer jabs. GUEST OVERVIEW: Dr Phillip Altman is a well-known Australian authority on clinical trials and regulatory affairs with more than 40 years' experience working with the Therapeutic Goods Administration (TGA). More recently Dr Altman has presented to the Cross Party COVID Inquiry held in Brisbane and NZ in relation to the COVID vaccines.

On today's show Dr Phillip Altman discusses why vaccine mandates are useless and unscientific and that the fear campaign is ramping up once again. GUEST OVERVIEW: Dr Phillip Altman is a well-known Australian authority on clinical trials and regulatory affairs with more than 40 years' experience working with the Therapeutic Goods Administration (TGA). More recently Dr Altman has presented to the Cross Party COVID Inquiry held in Brisbane and NZ in relation to the COVID vaccines.

On today's show Dr Phillip Altman will give his insights on the latest developments in the fight for medical freedom and justice. GUEST OVERVIEW: Dr Phillip Altman is a well-known Australian authority on clinical trials and regulatory affairs with more than 40 years' experience working with the Therapeutic Goods Administration (TGA). More recently Dr Altman has presented to the Cross Party COVID Inquiry held in Brisbane and NZ in relation to the COVID vaccines.

  Episode 105 is all about a revolutionary product made for those penises who want to last longer!   Well, that sounds epic so if you want to know more, listen here.   For this episode, we talk with Dr David Reiner, the brain behind the premature ejaculation spray or what most call, the ‘Delay Spray'.  So how does the spray work? Dr. David will spill all the proteins… err beans!   Some questions were raised by us giggly ladies throughout the discussion. Questions like - will the vagina be numb? Will it cause infection or affect fertility? Or will it even affect sperm quality?  Again, Dr. David has all the answers. He will explain in detail how the spray works, share some relatable analogies, why it is safe, and how rigorous the research and testing were to comply with the Therapeutic Goods Administration (TGA) requirements (like the FDA in Australia).   Yes, Steady Freddy is TGA-approved!   We know you're excited to listen and learn more about this revolutionary pleasure spray, so hit the play button below.   Spray away!    Links:   Delay Spray link >> USE CODE RSHEALTH15 to enjoy an exclusive discount for podcast listeners only.  Naomi Episode - https://thepenisproject.org/episode-12-meet-naomi-the-woman-who-had-her-prostate-removed-and-her-story/     ---------- Websites: https://thepenisproject.org/ https://rshealth.com.au/ https://penilerehabilitationprogram.com/ http://www.menshealthphysiotherapy.com.au/ http://prost.com.au/     Facebook: https://www.facebook.com/Restorativeshealthclinic   Instagram: https://www.instagram.com/rshealth_perth/   Linkedin: https://www.linkedin.com/in/melissa-hadley-barrett/   Music David Mercy https://open.spotify.com/artist/1HbvnltKu4XbWTmk0kpVB9?si=D1xP5dDVQK-zzNU3rViRWg   Producer Thomas Evans: The SOTA Process https://www.instagram.com/thesotaprocess/ https://open.spotify.com/show/4Jf2IYXRlgfsiqNARsY8fi

GUEST OVERVIEW: Dr Altman is a well-known Australian authority on clinical trials and regulatory affairs with more than 40 years' experience working with the Therapeutic Goods Administration (TGA). More recently Dr Altman has presented to the Cross Party COVID Inquiry held in Brisbane and NZ in relation to the COVID vaccines.

GUEST HOST: Robert Brennan On today's show Dr Altman discusses mRNA technology and his recent report, "The Time of COVID", which concludes, "The introduction and worldwide use of COVID-19 gene-based ‘vaccines' has been associated, in the short term, with far more deaths, illnesses, injuries, and disabilities than any other therapeutic agent in the history of medicine." Also, Alan Dana chats about the Alliance Airlines' flu and COVID vaccination policy as well as the importance of valid and informed consent. GUEST 1 OVERVIEW: Dr Altman is a well-known Australian authority on clinical trials and regulatory affairs with more than 40 years' experience working with the Therapeutic Goods Administration (TGA). More recently Dr Altman has presented to the Cross Party COVID Inquiry held in Brisbane and NZ in relation to the COVID vaccines. GUEST 2 OVERVIEW: Alan Dana is a member of the Global Aviation Advocacy Coalition. He Started flying in the UK in 1988, and now has accumulated 23,000 flight hours. Alan was recently fired after 14 years at JetStar - the low-cost airline owned by Qantas. The reason for termination, "Serious Misconduct", for not complying with the company vaccine mandate. Prior to this he was flying for British Airways, based in London Heathrow operating to the arctic Circle and Africa and the Middle East. Much of his training was completed outside of Chicago before working as an instructor and charter pilot in Palm Beach Florida, before relocating and flying in the Caribbean. He holds the American FAA, British and Australian Airline Pilot licences.

Experts say a new bivalent vaccine targeting both the original 2020 strain of COVID-19 and the Omicron variant could be a game-changer. And Australia could be on its way to acquiring the vaccine. Moderna has received permission from the Therapeutic Goods Administration [[TGA]] to apply for provisional approval for its bivalent vaccine to be used in Australia. - Մասնագէտներ կ'ըսեն որ երկարժէք պատուաստը որ կը թիրախաւորէ թէ սկզբնական 2020 թուականի ՔՈՎԻՏ-19 տեսակը և թէ Օմիքրոն տարբերակը կրնայ բեկումնային ըլլալ: Աւստրալիա պատուաստը ստանալու ճամբուն վրայ կը գտնուի:

On today's show Dr Phillip Altman will reflect upon his report “The Time of COVID” and the barrister level opinion regarding the responsibility of doctors to fully inform their patients about the risks associated with the COVID vaccines. GUEST 1 OVERVIEW: Dr Phillip Altman is a well known Australian authority on clinical trials and regulatory affairs with more than 40 years' experience working with the Therapeutic Goods Administration (TGA). More recently Dr Altman has presented to the Cross Party COVID Inquiry held in Brisbane and NZ in relation to the COVID vaccines. GUEST 2 OVERVIEW: Joachim Hagopian is a West Point graduate, former Army officer and author of Don't Let the Bastards Getcha Down. After the military, Joachim earned a master's degree in Clinical Psychology and worked as a licensed therapist. As an independent journalist for over 8 years, Joachim has written hundreds of articles for many news sites, like Global Research, lewrockwell.com and currently https://jamesfetzer.org/.

医药用品管理局 (Therapeutic Goods Administration TGA) 已暂准莫德纳（Moderna）药厂 Spikevax 疫苗用于 6 个月至 5 岁的儿童，两针最短可以相隔 28 天。

COVID-19 Vaccine Claims Scheme The Australian Government has implemented a claims scheme to enable eligible claimants who have received a TGA-approved COVID-19 vaccine to obtain compensation for recognised moderate to severe vaccine-related adverse events. To be eligible you need to have met all of the following. You must have: received a Therapeutic Goods Administration (TGA) approved COVID-19 vaccine met the definition of harm, like one of the clinical conditions listed in the policy been admitted to hospital as an inpatient because of the harm you suffered or seek a waiver losses or expenses of $1,000 or more, excluding pain and suffering, due to the COVID-19 vaccination. This is just my opinion. The Federal Government is treating the public like fools in offering a tax payer funded scheme for injuries from a vaccine that they insisted you take. J Fallon Apple Music J Fallon Spotify J Fallon YouTube The Slippery Slope Apple Podcasts The Slippery Slope YouTube The Slippery Slope Stitcher --- Send in a voice message: https://anchor.fm/jason-fallon/message

Mould growth has taken the shine off a popular “glow gummies” supplement, with an urgent recall issued for one of Swisse's collagen products. The Therapeutic Goods Administration (TGA) has put the spotlight on a batch of Swisse Beauty Collagen Glow Gummies, declaring a nationwide recall after mould was identified. See omnystudio.com/listener for privacy information.

The Novavax jab, which was approved by the Therapeutic Goods Administration (TGA) in January, is available at GP clinics, community pharmacies and state-run vaccine hubs for people aged 18 and over.

Show Notes for Episode Twenty of seX & whY: Interview With Dr Shirin Heidari Part 2: Gendro - Advancing Sex and Gender Equity in Science Research Host: Jeannette Wolfe Guest: Shirin Heidari PhD, virologist and experimental oncologist, founding President of Gendro. Part 2 of Interview with Dr Shirin Heidari This podcast focuses on Dr Heidari's work on systematically integrating the variables of sex and gender into different access points along the research pipeline. She helped start an organization called Gendro which is dedicated to this mission.  The three major gatekeeping posts that Gendro and other organizations are targeting are:  1)    Funding Require the inclusion of both male and female animals or justify an exclusion 2)    Ethical Review Boards These boards review research protocols prior to study enrollment to ensure that the researchers have designed their study to meet national and organization protocols designed to protect participants from being involved with unethical or dangerous practices. Traditionally these boards have been an overlooked area to target.   3)    Journals As many medical publishing house multiple journals, if they modify their standardized template to include query about sex and/or gender analyses, they have the power to rapidly change the expectations of authors and peer reviewers surrounding the inclusion of these factors. In addition, we talked about the SAGER guidelines SAGER guidelines a.k.a. Sex and Gender Equity in Research. These guidelines were put together by an international team of researchers in 2015 and geared towards giving researchers, journal editors, peer- reviewers and publishers better tools to include and evaluate the variables of sex and gender in scholarly work. Although the guidelines have increased the awareness and inclusion of these variables, and many journals have now adopted them, there continues to be a significant opportunity for more widespread use. A recent editorial highlights some of the barriers to utilization and possible concerns. Here is a synopsis of some of the remaining barriers.     Perceived Barrier Solution Mandated inclusion will significantly increase overall research costs from enrollment to additional statistical analysis Underscore that several countries have already been successful in tying initial funding with inclusion criteria which suggests that some of resistance is likely due to ingrained culture rather than significant financial barriers. Highlight that some countries have developed new supplemental funding to enhance adoption. *     Journal editors may have significant time and resource limitations that prohibit their ability to formally introduce or monitor SAGER guidelines.    Emphasize that optimizing science requires constant evolution and that as editors they are already well skilled in helping their journal comply with other required updates.  Including SAGER guidelines can enhance the quality of research their journal publishes and in turn enhance its reputation.    In additional, engaging publishers to invest in better science by making system wide changes in both editorial expectations and technical support (see below) could rapidly accelerate adoption. Peer reviewers may feel ill-equipped to evaluate for the proper inclusion of sex and gender in a review due to knowledge gaps in core principles surrounding sex and gender Provide access to available online trainingmodules such as those offered by the Canadian Institutes of Health Research. Enhance diversity training as who is at the table influences policy and priorities. Technical challenges. Many publishers use the same templates across multiple journals which may limit an individual journal's ability to change their own format. Engage editors to encourage publishers to update digital templated formatting to reflect SAGER principles. The inclusion of a requested digital check off page in submission requirements confirming guideline compliance, could serve both as a reminder cue to the author and a screening tool to journal staff to ensure that it is completed prior to forwarding material to reviewer. This would help minimize any additional time the reviewer would need to spend to ensure SAGER compliance.      * As an aside, identifying important sex-based differences in pre-clinical studies may ultimately be quite cost effective as they may lead to the design of more successful and cost-effective clinical trials We also discovered the opportunities to include the variables of sex and gender in COVID vaccine research and here are two important papers that Dr Heidari just published in this area.  A Systemic Review of the Sex and Gender Reporting in Covid-19 Clinical Trials. 75 initial published trials- 24% presented data broken down by sex and only 13% included in their discussion any discussion about potential sex differences. Time for Action: towards an intersectional gender approach to COVID-19 vaccine development and deployment that leaves no one behind.  Take home points from article sex and age-based differences in immunology may influence vaccine dosing/side effects sex based differences may influence gendered associated acceptance and uptake of vaccines (for example if it is known that women get more side effects with a vaccine it may influence another women's readiness to get vaccinated.) sociocultural associated factors can influence vaccine acceptance and uptake it is critical to have meaningful inclusion of gender diverse voices in high level research and policy decisions. This now becomes very relevant as we now know that there are significant sex differences in side effects in the vaccines including increased risk of myocarditis for males in Pfizer and Moderna  (According to a recent Australian study done by their equivalent of the FDA, the Therapeutic Goods Administration (TGA) numbers may occur up to 1 in 10,000 in younger men. Of note, they suggest that chance of getting myocarditis from Covid is likely 8-10x this risk.)  Conversely women are more likely to get increased risk of clotting with the J and J vaccine. Thanks for joining us!

The Therapeutic Goods Administration (TGA) has approved the Novavax vaccine for use in people aged 18 or over, becoming the fourth brand of COVID-19 jab that is being deployed in Australia to fight the ongoing pandemic. But why do we need another vaccine, how does it differ to the ones we already have, and why are some people saying it could convince anti-vaxxers to finally get inoculated? The Quicky speaks to an expert in immunology to answer these questions and find out everything you need you know about Novavax. CREDITS  Host: Claire Murphy With thanks to:  Professor Cassandra Berry - Professor of Immunology at Murdoch University in Western Australia Producer: Claire Murphy Executive Producer: Siobhán Moran-McFarlane Audio Producer: Ian Camilleri Subscribe to The Quicky at... https://mamamia.com.au/the-quicky/ CONTACT US Got a topic you'd like us to cover? Send us an email at thequicky@mamamia.com.au GET IN TOUCH: Feedback? We're listening! Call the pod phone on 02 8999 9386 or email us at podcast@mamamia.com.au Mamamia acknowledges the Traditional Owners of the Land we have recorded this podcast on, the Gadigal people of the Eora Nation. We pay our respects to their Elders past and present and extend that respect to all Aboriginal and Torres Strait Islander cultures. Just by reading or listening to our content, you're helping to fund girls in schools in some of the most disadvantaged countries in the world - through our partnership with Room to Read. We're currently funding 300 girls in school every day and our aim is to get to 1,000. Find out more about Mamamia at mamamia.com.au  Support the show: https://www.mamamia.com.au/mplus/ See omnystudio.com/listener for privacy information.

The Therapeutic Goods Administration (TGA) has given provisional approval to use the Pfizer vaccine against COVID for younger children, aged 5 to 11. Many people still have questions about vaccination and why it's necessary in younger children. We'll put those questions to an expert in childhood vaccination.

The Therapeutic Goods Administration (TGA) has provisionally approved a modified Pfizer vaccine for children aged 5 to 11.  See omnystudio.com/listener for privacy information.

The Therapeutic Goods Administration (TGA) has given provisional approval for children aged five to 11 to receive Pfizer COVID-19 vaccines. Vaccinations for the group are expected to kick off on January 10. See omnystudio.com/listener for privacy information.

The 'COVAX-19' vaccine is going through the process of approval from the Therapeutic Goods Administration (TGA) according to it's creator Dr Nikolai Petrovsky. See omnystudio.com/listener for privacy information.

Inaprubahan na ng Therapeutic Goods Administration (TGA )ang Pfizer booster shot para sa mga may edad 18 pataas. Ibibigay ang pangatlong dose ng bakuna, anim na buwan matapos ang ikalawang dose at inaasahang unang makakakuha nito ang mga residente na nasa aged care.

澳洲醫藥用品管理局（Therapeutic Goods Administration TGA）已經批准使用多款新冠病毒快速抗原測試，衛生部長亨特呼籲獲批的製造商進一步提出家居自行測試的申請，並預計全澳民眾在11月1日開始，可以在家中自行進行檢測。

Simply this. Let's all agree that vaccines for COVID-19 are better than the alternative RN and be done with it. Vaccine Information from Australian Health - https://bit.ly/covid19-vaccines-info-ausgov .  COVID-19 vaccine: Information for consumers and health professionals | Therapeutic Goods Administration (TGA) https://bit.ly/covid19-vaccine-info-consumers-health-professionals . Send your Nightmare Fuel via voice note to hello@itsalotpodcast.com LINKS Follow @itsalotpod on Instagram for videos, memes, and fun BTS stuff http://bit.ly/itsalot-instagram  Abbie's Instagram @abbiechatfield CREDITS Host:Abbie Chatfield Executive Producer and editor: Elise Cooper See omnystudio.com/listener for privacy information.

This episode brings you a wealth of information about the purpose behind ovulation and why it is the key event of the menstrual cycle. Humans are dependent on ovulation because it brings about pro-creation and using the birth control pill is going against this. Find out more about the symptoms of PCOS, misconceptions surrounding PCOS, the side effects of the birth control pill and when is considered too young to be going on the pill. Some of the scientific terms and content that were mentioned in this episode: Androgens: Besides testosterone, the other androgens are DHT and DHEA and Androstenedione Herbs (do check with your medical provider before taking any) for hirsutism: peony and licorice, saw palmetto, nettle, rosemary, spearmint, zinc as a nutritional supplement Testing for hormones: DUTCH test Amenorrhoea: absence of menstruation Hypothalamus: an area in the brain which controls the pituitary gland and the downstream effects including hormones Rebecca Hughes is a functional medicine naturopath with a special interest in skin conditions, women and children's health, autoimmunity and digestive health. Rebecca is committed to delivering high-quality, results-driven health care to her patients and, more broadly to excellence in the field of natural medicine. In fact, Rebecca won the 2020 BIMA Clinical Excellence award as recognition from the natural health industry of her outstanding skills as a practitioner! Rebecca's contribution to natural medicine extends beyond the clinical setting. She has lectured in nutrition and naturopathic degree programs, regulated complementary medicines at the Therapeutic Goods Administration (TGA), coordinated mental health guidance for the National Health and Medical Research Council (NHMRC), and contributed to a national reference text on Herbs and Natural Supplements. She brings a wealth of clinical experience to the treatment and management of acne, eczema, psoriasis, period pain, PMS, menopause, thyroid conditions, and IBS. Work with Rebecca at melbournefunctionalmedicine.com.au Associative reading: Lara Briden - Period Repair Manual Related podcast episodes: #89 Insulin Resistance & PCOS #76 A Functional Approach to PCOS #59 Overtraining & Undereating in Hypothalamic Amenorrhea with Sarah Widjaja #53 The Pill and PCOS --- Support this podcast: https://anchor.fm/nourishmel/support

Australians are being treated like mushrooms by our Federal and State Governments. We have indefensible lockdowns in Victoria, unsupported by any medical evidence except for the appearance of one or two Health sector figureheads. Our Federal Health Minister Greg Hunt has stated that he has no objection to these discredited lockdown measures, while all those charged with protecting our rights, including elected members of Parliament remain grossly uninformed about critical issues of vaccine safety and the costs of managing Covid19. They are treated with the same contempt, the only difference being that no public servant has been deprived of their income or right to earn a living. Senator Malcolm Roberts, Queensland Senator for One Nation tried valiantly in recent Senate Hearings to get some basic facts from the most senior health bureaucrats - Chief Medical Officer and the Head of the Therapeutic Goods Administration (TGA), the agency responsible for regulating therapeutic goods including vaccines. It's a disgrace when basic questions on matters such as Vaccine indemnity cannot be answered clearly. We know these people are smart; we know they are choosing their words wisely but the fact remains that our Prime Minister and his minions continue to scare and bully Australians into vaccination without providing the hard cold facts that allow for informed consent. Worse still, they are using Lockdowns, Border restrictions and Vaccine passports to achieve their political ends, without any regard for our liberties, our health or public finances. It's all about Politics Folks and it is despicable.   Asia Pacific Today. June 17, 2021 Asia Pacific Today believes that your opinion is legitimate. And we believe that our guests have something to say and that their opinion is also legitimate. Throughout the week, Mike Ryan has discussions about politics, polarising issues, current events, and more. We really are connecting with people all over the world that simply speak their mind. There's new videos throughout the week, every week. And we also need our audience to grow. It would really help us grow if you could subscribe to our Channel.

DIA Global Forum Australia/New Zealand Regional Editor Richard Day (University of New South Wales, Medicine, St. Vincent’s Hospital) and John Skeritt, Head of Australia’s Therapeutic Goods Administration (TGA), discuss regulatory strategies and other initiatives designed to help nurture clinical research and product development in Australia post-pandemic. With “Australia having had many fewer cases than comparable countries, we've actually become in very short time a very attractive global destination for clinical trials. And, in fact, because of our low numbers, the demand has significantly increased,” John explains. “For medicines, biologicals, and devices, for example, in the last six months of last year, July to December 2020, we actually had a 17% increase in the number of clinical trials, even though COVID was rife in some parts of Australia at that time.”

Therapeutic Goods Administration (TGA) tseem txheeb tias seb puas yog tshuaj AstraZeneca COVID-19 vaccine ua rau ib tug txiv neej ntawm Melbourne raug cov teeb meem ntshav khov, TGA thiab pej kum haiv cov kws kho mob tseem los txheeb seb puas yog tus tshuaj AstraZeneca vaccine ua rau muaj teeb meem ntshav khov, nom tswv xeev Queensland txhawj xeeb txog cov kev hno tshuaj vaccine rau tej neeg yuav kis tau kab mob virus yooj yim rau lub caij uas txhawj txog teb chaws Papua New Guinea cov neeg kis kab mob coob tuaj ntxiv, teb chaws Fabkis tau txwv nws tej pej xeem ua zaum 3 kom txhob muaj neeg kis kab mob COVID-19 coob ntxiv, tswj kev ruaj ntseg rau tsev dawb nruj tuaj ntxiv, America thiab Iran cov kev sib tham seb puas ua raws cov 2015 Nuclear deal, muaj ib lub football club ntawm Sydney npaj ib cov kev sib tw los pab tej neeg raug kev kub ntxhov ntawm teb chaws Phabmab,...

The ASX200 is eyeing a fall of 0.3% at the open.The Therapeutic Goods Administration (TGA) approved AstraZeneca's COVID-19 vaccine for use in Australia with it being produced in Melbourne by CSL (ASX:CSL).Bitcoin has reached US$50,000 after skyrocketing from US$5,000 2-years ago.Companies reporting:Fortescue Metals (ASX:FMG), Rio Tinto (ASX:RIO), Mount Gibson Iron (ASX:MGX), Whitehaven Coal (ASX:WHC), Sonic Healthcare (ASX:SHL), Coles (ASX:COL) and Domino's Pizza (ASX:DMP).Local trading ideas:UBS upgraded BHP (ASX:BHP) with a new $50 price target.Empired (ASX:EPD), Evolution Mining (ASX:EVN) and Zip (ASX:Z1P) are giving off bullish charting signals according to Trading Central.